Fabrice Ango Selected Research

Fabrice Ango Research Topics

1	Marijuana Abuse (Cannabis Abuse) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Dyskinesias (Dyskinesia) 01/2020
1	Kallmann Syndrome (Kallmann's Syndrome) 01/2017
1	Anosmia 01/2017
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2017
1	Type 2 Episodic Ataxia 08/2014
1	Episodic Ataxia 08/2014
1	Motor Disorders 08/2014
1	Ataxia (Dyssynergia) 08/2014
1	Nervous System Diseases (Neurological Disorders) 08/2014

1	serotonin 6 receptorIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017
1	Semaphorins (Semaphorin)IBA 01/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 08/2014
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 08/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2014
1	Calcium Channels (Calcium Channel)IBA 08/2014
1	Carbonic Anhydrase InhibitorsIBA 08/2014
1	voltage-dependent calcium channel (P-Q type)IBA 08/2014

1	Therapeutics 01/2020
1	Secondary Prevention 01/2020